Banter: An AEI Podcast

Scott Gottlieb on the CBD craze, vaping, and Juul: A conversation with the former FDA commissioner

08.08.2019 - By AEI PodcastsPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Is CBD oil safe? How about the Juul? And is it the government’s place to regulate either one? Former Food and Drug Administration (FDA) Commissioner Scott Gottlieb joined us to discuss these questions and more.

We started by asking Dr. Gottlieb about his recent column in The Washington Post, titled “The CBD craze is getting out of hand and the FDA need to act.” For those without much of a clue what CBD is or how the law treats it (like us), Dr. Gottlieb provides a perfect introduction and primer. Then, why are the kids so into Juul? Are vapes and e-cigs that much safer than normal tobacco products? And how should regulators think about all these smoking alternatives?

Scott Gottlieb, MD, returned to AEI as a resident fellow in 2019 after serving as the 23rd commissioner of the Food and Drug Administration. At AEI, he continues his work on improving public health through entrepreneurship and medical innovation and on expanding regulatory approaches to maintain patient and physician autonomy.

You can subscribe to “Banter” on iTunes, Stitcher, or the podcast player of your choice, and archived episodes can be found at www.aei.org/feature/banter. This is Banter episode #374.

Related reading:

The aforementioned Washington Post column

The FDA’s challenge on e-cigs

More episodes from Banter: An AEI Podcast